Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Naloxone Pre-Filled Syringe Life Science Investing
U.S. Food and Drug Administration Approves Portola Pharmaceuticals’ Prior Approval Supplement for Andexxa Life Science Investing
Windtree Therapeutics to Hold Investor Call Thursday, January 3, 2019 at 8:00 a.m. EST Biotech Investing
BriaCell Announces Switch to Novel Frozen Formulation for Lead Cancer Drug Candidate, Upcoming Attendance at Biotech Showcase™ 2019 and Presentation at Keystone Symposia Conference Biotech Investing
